Drugs Xagena
Prexige is a selective COX-2 inhibitor in the class of drugs called NSAIDs ( non-steroidal anti-inflammatory drugs ). In New Zealand, Novartis has informed Health Care Professionals of important new ...
Human growth hormone ( GH ), or Somatropin, is widely used as an antiaging therapy, although its use for this purpose has not been approved by the FDA ( Food and Drug Administration ). Researchers ...
The FDA ( Food and Drug Administration ) has licensed a new vaccine to protect against smallpox, a highly contagious disease with the potential to be used as a deadly bioterror weapon. The vaccine, ...
The FDA ( Food and Drug Administration ) approved Evista ( Raloxifene ) for reducing the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high ri ...
Johnson and Johnson and FDA( Food and Drug Administration ) informed Healthcare Professionals that the Warnings section of the prescribing information for Haloperidol ( Halcion ) has been revised t ...
Premature ejaculation is a frequent male sexual complaint that is mediated mainly by disturbances of serotonergic neurotransmission and certain serotonin ( 5-HT ) receptors and, to a lesser extent, ox ...
Sibutramine ( Meridia, Reductil ), a serotonin and norepinephrine reuptake inhibitor ( SNRI ), is an antiobesity agent marketed in Canada since February 2001. Sibutramine is indicated as adjunctive th ...
Data Safety Monitoring Boards ( DSMB ) has recommended to stop patient enrollment in the Aprotinin ( marketed as Trasylol ) treatment group arm of the: BART ( Blood conservation using antifibrinolyt ...
The FDA ( Food and Drug Administration ) has approved Lyrica ( Pregabalin ), the first drug to treat fibromyalgia, a disorder characterized by pain, fatigue and sleep problems. Lyrica reduces pain ...
Clozapine ( Clozaril ), marketed in Australia since 1993, is an effective antipsychotic for the management of treatment-resistant schizophrenia. All patients taking Clozapine are enrolled in a registr ...
Mirtazapine ( Remeron ), is an analogue of Mianserin and, like Mianserin, has been associated with reports of neutropenia and agranulocytosis. Since 2001 when the drug was registered, blood dyscras ...
The EMEA ( European Medicines Agency ) has recommended contraindicating Acomplia ( Rimonabant ), in patients with ongoing major depression or who are being treated with antidepressants, because of ...
The EMEA ( European Medicines Agency ) has recommended the withdrawal of the marketing authorisation for medicinal products containing Veralipride. The EMEAs Committee for Medicinal Products for Hu ...
The full prescribing information for Xolair ( Omalizumab ) includes a new boxed WARNING, updated Warnings, Precautions, and Adverse Reactions. A New Medication Guide about the risk of anaphylaxis fo ...
The FDA ( Food and Drug Administration ) announced that it is permitting the restricted use of Zelnorm ( Tegaserod ) under a treatment investigational new drug ( IND ) protocol to treat irritable bowe ...
The NICE ( National Institute for Health and Clinical Excellence ) has published final guidance on the use of Rituximab ( Mabthera; US: Rituxan ) for the treatment of rheumatoid arthritis and Adalimum ...
Aclasta ( Zoledronic acid 5 mg ) has received European Union approval as the first once-yearly treatment for women with postmenopausal osteoporosis. Unlike oral bisphosphonate therapies taken dai ...
The FDA ( Food and Drug Administration ) has approved labeling changes for erectile dysfunction drugs in the class that includes Cialis ( Tadalafil ), Levitra ( Vardenafil ), and Viagra ( Sildenafil ) ...
The FDA ( Food and Drug Administration ) has announced that, at the agency's request, Bayer Pharmaceuticals has agreed to a marketing suspension of Trasylol ( Aprotinin ), a drug used to control bleed ...
Novartis has provided a safety update to European regulators of pooled data showing numerically less frequent liver enzyme elevations in patients who took either 50 mg per day or 50 mg twice daily of ...
The FDA ( Food and Drug Administration ) has approved revised boxed warnings and other safety-related product labeling changes for erythropoiesis-stimulating agents ( ESAs ), which treat certain types ...
The FDA ( Food and Drug Administration ) has approved Nexavar ( Sorafenib ) for use in patients with a form of liver cancer known as hepatocellular carcinoma, when the cancer is inoperable. Nexavar ...
The FDA ( Food and Drug Administration ) announced that the manufacturer of Avandia ( Rosiglitazone ), a drug used to treat type 2 diabetes, has agreed to add new information to the existing boxed war ...
Voltaren Gel ( Diclofenac sodium topical gel ) 1% has received FDA approval as the first topical prescription treatment that patients can apply directly to sites of pain associated with osteoarthritis ...
An article in of The Lancet Infectious Diseases has raised the question about increased mortality with the use of Cefepime ( Yahav D, Paul M, Fraser A et al. Efficacy and safety of Cefepime: a systema ...
The FDA ( Food and Drug Administration ) has approved Bystolic ( Nebivolol ), a beta blocker, for the treatment of high blood pressure. The safety and efficacy of Bystolic in lowering blood press ...
The purpose of the study by researchers from American University of Beirut Medical Center, Beirut, Lebanon, was to identify risk factors for subclinical hypothyroidism ( TSH, thyroid-stimulating hormo ...
Zonisamide ( Zonegran ) is a sulphonamide derivative that inhibits carbonic anhydrase; it resembles Topiramate ( Topamax ). The main clinical trial, a double-blind study lasting 36 weeks, compared ...
Bisphosphonates constitute a group of compounds and their structure is based on that of pyrophosphate:a compound that regulated precipitation and extraction of minerals from the bone, albeit they ar ...
Vitamins C and E and Beta-Carotene, either individually or in combination, do not appear to reduce the risk of cardiovascular events or death among women at high risk for heart disease. Oxidative d ...
Zolpidem ( Stilnox ) was marketed in Australia in late 2000 for the short term treatment of insomnia. It is structurally unrelated to the benzodiazepines, but has a similar pharmacological action. ...
The FDA ( Food and Drug Administration ) is aware of a potential safety issue related to Rosiglitazone ( Avandia ). Safety data from a pooled analysis of controlled clinical trials have shown a signi ...
The FDA ( Food and Drug Administration ) is aware of a potential safety issue related to Avandia ( Rosiglitazone ), a drug approved to treat type 2 diabetes. Safety data from controlled clinical tria ...
The FDA ( Food and Drug Administration ) has approved Neupro ( Rotigotine transdermal system ), a skin patch designed to treat symptoms of early Parkinson's disease. Rotigotine is a drug not previ ...
The FDA ( Food and Drug Administration ) proposed that makers of all antidepressant medications update the existing black box warning on their products' labeling to include warnings about increased ri ...
The EMEAs Committee for Medicinal Products for Human Use ( CHMP ) reminds healthcare professionals that Baraclude ( Entecavir ) has not been evaluated for the treatment of patients with chronic hepat ...
Eli Lilly announced that the European Medicines Agency ( EMEA ) has granted Enzastaurin, an investigational, multi-targeted, oral, cancer agent, orphan drug designation for the treatment of diffuse la ...
The FDA ( Food and Drug Administration ) announced that manufacturers of Pergolide drug products, which are used to treat Parkinsons disease, will voluntarily remove these drugs from the market becau ...
The FDA ( Food and Drug Administration ) has requested that all manufacturers of sedative-hypnotic drug products, a class of drugs used to induce and/or maintain sleep, strengthen their product labeli ...
The FDA ( Food and Drug Administration ) has approved Tykerb ( Lapatinib ), a new targeted anti-cancer treatment, to be used in combination with Capectabine ( Xeloda ), another cancer drug, for patien ...
Tumour necrosis factor alpha ( TNF-alpha ) is a cellular protein produced by the immune system and is an important mediator of many diseases, including inflammatory arthritis and inflammatory bowel di ...
Gallstones and alcohol are the two most common causes of pancreatitis, but medicines are estimated to account for about 2 to 5% of cases. ADRAC ( Adverse Drug Reactions Advisory Committee ) has recei ...
Leflunomide ( Arava ) is a disease-modifying anti-rheumatic drug ( DMARD ) for the treatment of rheumatoid arthritis, which has been available in Australia since 2000. A publication described 7 Aust ...
The FDA ( Food and Drug Administration ) announced the approval of Tekturna ( Aliskiren ) tablets for the treatment of hypertension, which causes increased risk of stroke, myocardial infarction, kidne ...
The FDA ( Food and Drug Administration ) has approved Humira ( Adalimumab ) to treat adult patients with moderately to severely active Crohn's disease, a chronic inflammatory disease of the intestines ...
Roche Laboratories, following discussion with the FDA ( Food and Drug Administration ), informed Health Care Professionals of important safety information regarding the termination of the Heart Spare ...
The FDA ( Food and Drug Administration ) directed the manufacturers of all drug products approved for the treatment of Attention Deficit Hyperactivity Disorder ( ADHD ) to develop Patient Medication G ...
Levofloxacin ( Levaquin ) is a broad-spectrum fluoroquinolone antibiotic that is indicated for the treatment of certain respiratory tract, skin and urinary tract bacterial infections in adults. Dysgly ...
The FDA ( Food and Drug Administration ) announced the approval of antihemophilic factor / von Willebrand factor complex ( human ), Alphanate. The product is approved for patients undergoing surgery ...
The FDA ( Food and Drug Administration ) announced revisions to the labeling for the antibiotic Ketek ( Telithromycin ) designed to improve the safe use of Ketek by patients. The changes include the r ...
